Ensysce Biosciences, Inc. (ENSC) vs Imunon, Inc. (IMNN)
Ensysce Biosciences, Inc. and Imunon, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Imunon, Inc. are of similar size ($7.8M and $7.3M). Imunon, Inc. grew revenue faster over the last twelve months: 0.00% against −39.3%. Imunon, Inc. has the higher net margin (0.00% vs −280.5%) and the lower return on invested capital (−324.4% vs 0.00%). Across the 17 metrics below, Imunon, Inc. leads on 9 and Ensysce Biosciences, Inc. on 8.
Valuation
Profitability
| Metric | ENSC | IMNN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (281.32%) | 0.00% | 0.00% |
| Net margin | (280.49%) | 0.00% | 0.00% |
| Free cash flow margin | (196.76%) | 0.00% | 0.00% |
| Return on equity | (1,295.01%) | (641.02%) | (57.72%) |
| Return on assets | (295.92%) | (123.93%) | (49.22%) |
| Return on invested capital | 0.00% | (324.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack